Evidence map›Paper›PMID 25911169›Full record

ArticlePurinergic signalling2015

Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.

Zhichao Zhou, Uthra Rajamani, Hicham Labazi, Stephen L Tilley, Catherine Ledent, Bunyen Teng, S Jamal Mustafa

Open access · bronzeAbstract read
In one paragraph

Article in Purinergic signalling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. CD73Journal of extracellular vesicles · 2020
    Article
  6. Activation of adenosine AJournal of pharmacological sciences · 2019
    Article
  7. Enhanced AEuropean journal of pharmacology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Zhichao ZhouDepartment of Physiology and Pharmacology, Center for Cardiovascular and Respiratory Sciences, Clinical and Translational Science Institute, West Virginia University, Morgantown, WV, 26506-9104, USA.
Uthra Rajamani
Hicham Labazi
Stephen L Tilley
Catherine Ledent
Bunyen Teng
S Jamal Mustafa
West Virginia University · USUniversité Libre de Bruxelles · BEUniversity of North Carolina at Chapel Hill · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Reagan Curtis · 2012 to 2026
$81.0M
MECHANISMS OF CORONARY FLOW REGULATION BY ADENOSINER01HL027339 · NHLBI · WEST VIRGINIA UNIVERSITY · PI MUSTAFA, S. JAMAL · 1986 to 2015
$5.0M
Role of Adenosine in Allergic Lung DiseaseR01HL071802 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TILLEY, STEPHEN LLOYD · 2004 to 2011
$2.6M
Role of CYP P450s in the Regulation of Vascular Tone through Adenosine ReceptorsR01HL094447 · NHLBI · WEST VIRGINIA UNIVERSITY · PI MUSTAFA, S. JAMAL · 2009 to 2013
$2.4M
CALCIUM SENSITIVITY--ROLE OF PKC AND MAP KINASEF32HL009444 · NHLBI · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SAMARDZIJA, MICHAEL R · 1996 to 1998
–
NHLBI NIH HHS F32 HL009444NHLBI NIH HHS HL027339NHLBI NIH HHS HL071802NHLBI NIH HHS HL09444NHLBI NIH HHS R01 HL027339NHLBI NIH HHS R01 HL071802NHLBI NIH HHS R01 HL094447NIGMS NIH HHS U54 GM104942NIGMS NIH HHS U54GM104942
6 · The paper itself

Abstract

Adenosine increases coronary flow mainly through the activation of A2A and A2B adenosine receptors (ARs). However, the mechanisms for the regulation of coronary flow are not fully understood. We previously demonstrated that adenosine-induced increase in coronary flow is in part through NADPH oxidase (Nox) activation, which is independent of activation of either A1 or A3ARs. In this study, we hypothesize that adenosine-mediated increase in coronary flow through Nox activation depends on A2A but not A2BARs. Functional studies were conducted using isolated Langendorff-perfused mouse hearts. Hydrogen peroxide (H2O2) production was measured in isolated coronary arteries from WT, A2AAR knockout (KO), and A2BAR KO mice using dichlorofluorescein immunofluorescence. Adenosine-induced concentration-dependent increase in coronary flow was attenuated by the specific Nox2 inhibitor gp91 ds-tat or reactive oxygen species (ROS) scavenger EUK134 in both WT and A2B but not A2AAR KO isolated hearts. Similarly, the A2AAR selective agonist CGS-21680-induced increase in coronary flow was significantly blunted by Nox2 inhibition in both WT and A2BAR KO, while the A2BAR selective agonist BAY 60-6583-induced increase in coronary flow was not affected by Nox2 inhibition in WT. In intact isolated coronary arteries, adenosine-induced (10 μM) increase in H2O2 formation in both WT and A2BAR KO mice was attenuated by Nox2 inhibition, whereas adenosine failed to increase H2O2 production in A2AAR KO mice. In conclusion, adenosine-induced increase in coronary flow is partially mediated by Nox2-derived H2O2, which critically depends upon the presence of A2AAR.

Indexed as

AminopyridinesAnimalsCoronary VesselsHeartHydrogen PeroxideMice, Inbred C57BLMice, KnockoutMyocardiumNADPH OxidasesReceptor, Adenosine A2AReceptor, Adenosine A2BVasodilationAminopyridinesBAY 60-6583Hydrogen PeroxideNADPH OxidasesReceptor, Adenosine A2AReceptor, Adenosine A2B

Identifiers

PMID25911169
PMCPMC4425720
OpenAlexW1999966814

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.